Yosef Krespi, MD

Yosef Krespi, MD, is a renowned medical facility nestled in the bustling city of New York, NY. Known for its exceptional standards of care and commitment to patient well-being, this establishment offers a wide array of medical services designed to cater to diverse healthcare needs. From primary care to cutting-edge surgical interventions, Yosef Krespi, MD, is dedicated to providing top-notch medical treatments to its patients. At Yosef Krespi, MD, a team of seasoned professionals actively engages in medical research, education, and community health initiatives, striving to enhance patient care and healthcare outcomes. This esteemed facility prides itself on fostering innovation and forging meaningful partnerships within the healthcare landscape. By staying at the forefront of medical advancements and embracing a patient-centered approach, Yosef Krespi, MD, stands as a beacon of excellence in the heart of New York, NY. Generated using this brand's available information

Dr. George A. (Jack) Cioffi is an internationally recognized glaucoma scientist and clinician and is the Edward S. Harkness Professor and Chair of the Department of Ophthalmology at Columbia University Vagelos College of Physicians and Surgeons since 2012. He also holds the Jean and Richard Deems Endowed Professorship and is the Ophthalmologist-in-Chief at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. From 2014 to 2023, Dr. Cioffi served as the President of ColumbiaDoctors, the multi-specialty faculty practice organization of more than 2,500 clinicians from Columbia University Irving Medical Center and was concurrently appointed Vice Dean of Clinical Affairs. Dr. Cioffi formerly held the Richard G. Chenoweth Chair of Ophthalmology at the Devers Eye Institute and was the Chief Medical Officer & Senior Vice President at Legacy Health System in Portland, Oregon. He received his medical degree at the University of South Carolina, completed a residency in ophthalmology at the University of Maryland where he also served as Chief Resident, and a fellowship in Research & Clinical Glaucoma at Devers Eye Institute under Dr. E. Michael Van Buskirk. Subsequently, he completed the inaugural Harvard Business School program in Managing Healthcare Delivery. Dr. Cioffi is the Editor-in-Chief of Journal of Academic Ophthalmology, the official journal of the Association of University Professors of Ophthalmology (AUPO). As well, he is Editor Emeritus of the Journal of Glaucoma, after serving for 10 years as the Editor-in-Chief, and he is the past Chair of the Basic and Clinical Science Course for the American Academy of Ophthalmology. He is the Chair of the Scientific Advisory Committee for the Glaucoma Research Foundation in San Francisco. He is a past President of the Oregon Academy of Ophthalmology and has served as a member of the FDA Ophthalmology/Dermatology Advisory Committee for drug approval. He also served on the Board of Directors for the Foundation for Medical Excellence and was selected by the Governor John Kitzhaber to serve on the Oregon Health Policy Board’s Outcomes & Quality taskforce. Dr. Cioffi, a physician for more than 30 years, has published over 250 articles, has enjoyed support from the National Eye Institute of the National Institutes of Health for more than two decades. He has delivered numerous named lectures and has received the Honor Award, the Senior Honor Award and two Secretariat Awards from the AAO. He has mentored more than 50 clinical and post-doctoral fellows over his career. These clinicians and scientists are now at academic institutions and in practices around the U.S., Canada, Europe, Asia, and Australia.

Dr. Izak Faiena MD, MSCR is a urologic oncologist with a specialized focus on prostate cancer. His expertise spans advanced diagnostic techniques, such as MRI fusion and transperineal biopsy, as well as cutting-edge treatments including focal therapy and robotic surgery. With a solid foundation from the Albert Einstein College of Medicine, where he graduated with Alpha Omega Alpha honors, Dr. Faiena went on to complete his urology residency at Rutgers Robert Wood Johnson Medical School. During this time, he earned multiple research awards for his contributions to prostate and bladder cancer studies. Following his residency, Dr. Faiena pursued a fellowship in urologic oncology and earned a Master's in Clinical Research from the esteemed UCLA Institute of Urologic Oncology and the Clinical and Translational Science Institute. His work here garnered significant research funding and resulted in impactful publications on clinical trials in urologic cancers. Currently, Dr. Faiena is dedicated to advancing the field of prostate cancer through innovative clinical trials, targeting both localized and advanced stages of the disease. His groundbreaking research has been featured in top national and international medical journals, reflecting his commitment to improving patient outcomes and advancing cancer care.